SCHEMBL17211812

SCHEMBL17211812

C=CCC1(F)CCc2cc(C(=C)/C=C\C(=C)N)ccc2C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14061907 0.74 TDP2 (0.42) —
SCHEMBL17211815 0.72 ALDH1A1 (0.35) —
SCHEMBL14062000 0.68 TDP2 (0.38) —
SCHEMBL17211814 0.68 — —
SCHEMBL14062387 0.65 DGAT1 (0.62) —
SCHEMBL17211835 0.63 DGAT1 (0.66) —
SCHEMBL14062385 0.61 DGAT1 (0.65) —
SCHEMBL629836 0.57 SMN1; SMN2 (0.53) —
SCHEMBL18101502 0.57 — —
SCHEMBL16263342 0.56 HTT (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9242929-B2 Compounds as diacylglycerol acyltransferase inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2016-01-26 — — US disclosed
US-20150307445-A1 Novel Compounds as Diacylglycerol Acyltransferase Inhibitors GlaxoSmith Kline Intellectual Property (No.2) Limited (GB) 2015-10-29 — — US disclosed
Send feedback